Neuroscience

Why don’t we remember specific events during those crucial first few years, when our brains worked overtime to learn so much? A new Yale study finds evidence that we do form memories, but can’t retrieve them.

There's newfound hope for stroke patients in recovery, with what researchers believe is the very first drug that can comprehensively deliver rehabilitation without the need for challenging long-term physical therapy.

Scientists have finally pinned down a protein that’s largely responsible for Parkinson’s disease. Known as PINK1, the protein has been linked to the disease for decades but its structure and how to switch it back on have remained elusive – until now.

The first-ever "biological computer" powered by human cells, which form an ever-learning neural network, has been launched. It's an entirely new kind of AI – Synthethic Biological Intelligence – and not even its creators can predict its full potential.

A fascinating 2022 study found two common viruses may be working in tandem to trigger the earliest stages of Alzheimer’s disease. The findings were just the beginning of an ever-growing body of evidence implicating viral infections in dementia.

You lean back from the dinner table, feeling like you physically couldn’t fit another bite in – but then someone offers pie and you just can’t say no. Scientists have now identified the neurons behind the “dessert stomach” phenomenon.

GLP-1 drugs have reportedly changed people's relationship with more than just food, but it's been largely anecdotal. Now, there's evidence that Ozempic blocks alcohol cravings – which could be a game-changer for people who want to cut back on booze.

A novel study testing the effects of caffeine on the human brain found daily consumption can significantly reduce the volume of one's gray matter. Whether this is a good or bad thing is unclear but that daily cup of coffee is certainly doing something.

Americans will soon have access to an infusion treatment that provides round-the-clock relief of Parkinson's symptoms. The US FDA has green-lit this innovative drug delivery system, which is expected to be available in the fourth quarter of 2025.

In the first study of its kind, scientists have used extensive data to identify that adults with ADHD have a significantly lower life expectancy than their neurotypical peers. This unprecedented research should serve as a serious wake-up call.

We've never been closer to accurately assessing whether someone is more susceptible to developing depression due to their biology, with 293 new gene variants found to play a role in ramping up the risk factor. That's 42% more than previously known.

Individuals who suffer head trauma from sports, accidents, or other causes often go on to develop neurodegenerative diseases like Parkinson's or Alzheimer's. A new study sheds light on why that might be and offers a way to prevent it.